SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338853
Filing Date
2017-11-09
Accepted
2017-11-09 16:36:48
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d656262d10q.htm 10-Q 545426
2 EX-10.27 d656262dex1027.htm EX-10.27 302083
3 EX-31.1 d656262dex311.htm EX-31.1 9877
4 EX-31.2 d656262dex312.htm EX-31.2 9874
5 EX-32.1 d656262dex321.htm EX-32.1 5787
12 GRAPHIC g656262page48.jpg GRAPHIC 54432
13 GRAPHIC g656262page58.jpg GRAPHIC 41712
  Complete submission text file 0001193125-17-338853.txt   3086176

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldx-20170930.xml EX-101.INS 388729
7 XBRL TAXONOMY EXTENSION SCHEMA aldx-20170930.xsd EX-101.SCH 35219
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20170930_cal.xml EX-101.CAL 42079
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20170930_def.xml EX-101.DEF 103612
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20170930_lab.xml EX-101.LAB 281303
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20170930_pre.xml EX-101.PRE 196442
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 171191411
SIC: 2834 Pharmaceutical Preparations